Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 394

1.

Social networks for young patients with cancer: the time for system agility.

Ben-Aharon I, Goshen-Lago T, Fontana E, Smyth E, Caballero MGC, Lordick F.

Lancet Oncol. 2019 Jun;20(6):765. doi: 10.1016/S1470-2045(19)30346-8. No abstract available.

PMID:
31162090
2.

More is not always better: triplet chemotherapy and advanced gastric cancer.

Fokter-Dovnik N, Smyth EC.

Lancet Gastroenterol Hepatol. 2019 Jul;4(7):490-491. doi: 10.1016/S2468-1253(19)30145-1. Epub 2019 May 14. No abstract available.

PMID:
31101533
3.

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer.

Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang YJ, Li L, Davis KL, Kaye JA.

Curr Med Res Opin. 2019 Jun 12:1-12. doi: 10.1080/03007995.2019.1615422. [Epub ahead of print]

PMID:
31060392
4.

Injury prevention strategies specific to pre-elite athletes competing in Olympic and professional sports - A systematic review.

Smyth EA, Newman P, Waddington G, Weissensteiner JR, Drew MK.

J Sci Med Sport. 2019 Mar 12. pii: S1440-2440(18)30325-6. doi: 10.1016/j.jsams.2019.03.002. [Epub ahead of print] Review.

PMID:
30930142
5.

The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.

Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F.

Eur J Cancer. 2019 May;112:1-8. doi: 10.1016/j.ejca.2019.01.106. Epub 2019 Mar 15. Review.

PMID:
30878666
6.

Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.

Michalarea V, Fontana E, Garces AI, Williams A, Smyth EC, Picchia S, Rao S, Chau I, Cunningham D, Bali MA.

Curr Probl Cancer. 2019 Feb 21. pii: S0147-0272(18)30318-0. doi: 10.1016/j.currproblcancer.2019.01.008. [Epub ahead of print]

PMID:
30827742
7.

Quenching by sodium thiosulfate does not influence 16S rRNA gene sequencing profiles of reclaimed water from three sites in the Mid-Atlantic, United States.

Allard SM, Solaiman S, Callahan MT, Bui A, Craddock H, Haymaker J, Foust D, Duncan R, Smyth E, Mongodin EF, Hashem F, May E, Micallef SA, Sapkota AR.

Environ Res. 2019 May;172:296-300. doi: 10.1016/j.envres.2019.02.022. Epub 2019 Feb 15.

PMID:
30822563
8.

Little cigars and cigarillos harbor diverse bacterial communities that differ between the tobacco and the wrapper.

Chattopadhyay S, Smyth EM, Kulkarni P, Babik KR, Reid M, Hittle LE, Clark PI, Mongodin EF, Sapkota AR.

PLoS One. 2019 Feb 22;14(2):e0211705. doi: 10.1371/journal.pone.0211705. eCollection 2019.

9.

Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk.

Taylor KA, Smyth E, Rauzi F, Cerrone M, Khawaja AA, Gazzard B, Nelson M, Boffito M, Emerson M.

Br J Pharmacol. 2019 Apr;176(7):879-889. doi: 10.1111/bph.14589. Epub 2019 Mar 14.

PMID:
30681136
10.

Genomic loss of heterozygosity and survival in the REAL3 trial.

Smyth EC, Cafferkey C, Loehr A, Waddell T, Begum R, Peckitt C, Harding TC, Nguyen M, Okines AF, Raponi M, Rao S, Watkins D, Starling N, Middleton GW, Wadsley J, Mansoor W, Crosby T, Wotherspoon A, Chau I, Cunningham D.

Oncotarget. 2018 Nov 30;9(94):36654-36665. doi: 10.18632/oncotarget.26336. eCollection 2018 Nov 30.

11.

Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer.

Chénard-Poirier M, Smyth EC.

Drugs. 2019 Jan;79(1):1-10. doi: 10.1007/s40265-018-1032-1.

PMID:
30604292
12.

Food for thought. Malnutrition risk associated with increased risk of healthcare-associated infection.

Fitzpatrick F, Skally M, O'Hanlon C, Foley M, Houlihan J, Gaughan L, Smith O, Moore B, Cunneen S, Sweeney E, Dinesh B, O'Connell K, Smyth E, Humphreys H, Burns K.

J Hosp Infect. 2019 Mar;101(3):300-304. doi: 10.1016/j.jhin.2018.12.012. Epub 2018 Dec 25.

PMID:
30590089
13.

Two steps forward and one step back.

Lordick F, Smyth EC.

Nat Rev Clin Oncol. 2019 Feb;16(2):69-70. doi: 10.1038/s41571-018-0154-4. No abstract available.

PMID:
30575811
14.

Dialysis independence following single-agent daratumumab in refractory myeloma with renal failure.

Smyth E, Glavey S, Melotti D, Thornton P, Sargent J, Conlon P, Murphy P, Quinn J.

Ir J Med Sci. 2018 Dec 19. doi: 10.1007/s11845-018-1951-6. [Epub ahead of print] No abstract available.

PMID:
30569372
15.

Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer.

van den Ende T, Smyth E, Hulshof MCCM, van Laarhoven HWM.

Best Pract Res Clin Gastroenterol. 2018 Oct - Dec;36-37:45-52. doi: 10.1016/j.bpg.2018.11.005. Epub 2018 Nov 22. Review.

PMID:
30551856
16.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A.

Ann Oncol. 2018 Dec 1;29(12):2356-2362. doi: 10.1093/annonc/mdy407.

17.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):19-33. doi: 10.1093/annonc/mdy502.

PMID:
30475956
18.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Kato K, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Nakajima TE, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY.

Ann Oncol. 2019 Jan 1;30(1):34-43. doi: 10.1093/annonc/mdy498.

PMID:
30475943
19.

Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.

Bromberg JS, Hittle L, Xiong Y, Saxena V, Smyth EM, Li L, Zhang T, Wagner C, Fricke WF, Simon T, Brinkman CC, Mongodin EF.

JCI Insight. 2018 Oct 4;3(19). pii: 121045. doi: 10.1172/jci.insight.121045.

20.

Value of a hospital-wide point prevalence survey of carbapenemase-producing Enterobacterales - low-level prevalence confirmed.

Cafferkey J, Skally M, Finn C, Donlon S, Fitzpatrick M, Burns K, O'Connell K, Fitzpatrick F, Smyth E, Humphreys H.

J Hosp Infect. 2019 Feb;101(2):191-194. doi: 10.1016/j.jhin.2018.09.004. Epub 2018 Sep 17. No abstract available.

PMID:
30237120
21.

Immunotherapy is not for all comers in chemotherapy-refractory advanced gastric cancer. Better predictive biomarkers are needed.

Smyth EC, Cervantes A.

Ann Oncol. 2018 Oct 1;29(10):2027-2028. doi: 10.1093/annonc/mdy331. No abstract available.

PMID:
30137184
22.

MUC16 Mutations and Prognosis in Gastric Cancer: A Little Goes a Long Way.

Smyth EC, Fitzgerald RC.

JAMA Oncol. 2018 Dec 1;4(12):1698-1699. doi: 10.1001/jamaoncol.2018.2803. No abstract available.

23.

Job satisfaction and career intentions of registered nurses in primary health care: an integrative review.

Halcomb E, Smyth E, McInnes S.

BMC Fam Pract. 2018 Aug 7;19(1):136. doi: 10.1186/s12875-018-0819-1.

24.

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma.

Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M, Maisey N, Allum WH, Smyth E, Gossage JA, Lagergren J, Cunningham D, Green M; Guy's and St Thomas' Oesophago-Gastric Research Group and PROGRESS Study Group.

Br J Surg. 2018 Nov;105(12):1639-1649. doi: 10.1002/bjs.10900. Epub 2018 Jul 26.

PMID:
30047556
25.

Paradoxical Bactericidal Effects of Hydrophobic Lung Surfactant Proteins and Their Peptide Mimics Using Liposome Molecular Trojan.

Dutta K, Nag K, Booth V, Smyth E, Dueck H, Fritzen-Garcia M, Ghosh C, Panda AK.

J Oleo Sci. 2018 Aug 1;67(8):1043-1057. doi: 10.5650/jos.ess18026. Epub 2018 Jul 17.

26.

Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom.

La EM, Smyth EN, Talbird SE, Li L, Kaye JA, Lin AB, Bowman L.

Eur J Cancer Care (Engl). 2018 Sep;27(5):e12862. doi: 10.1111/ecc.12862. Epub 2018 Jun 21.

27.

Translational research and application of basic biology to clinical trial development in GI cancers.

Smyth E, Khan K, Valeri N.

Ann Transl Med. 2018 May;6(9):164. doi: 10.21037/atm.2018.05.05. Review.

28.

Sensory dominance and multisensory integration as screening tools in aging.

Murray MM, Eardley AF, Edginton T, Oyekan R, Smyth E, Matusz PJ.

Sci Rep. 2018 Jun 11;8(1):8901. doi: 10.1038/s41598-018-27288-2.

29.

Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma.

Smyth EC, Petty RD.

Lancet. 2018 Jul 14;392(10142):97-98. doi: 10.1016/S0140-6736(18)31277-7. Epub 2018 Jun 4. No abstract available.

PMID:
29880232
30.

Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future.

Aggelis V, Cunningham D, Lordick F, Smyth EC.

Ann Oncol. 2018 Jun 1;29(6):1377-1385. doi: 10.1093/annonc/mdy183.

PMID:
29771279
31.

COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer.

Garg R, Blando JM, Perez CJ, Lal P, Feldman MD, Smyth EM, Ricciotti E, Grosser T, Benavides F, Kazanietz MG.

Oncogene. 2018 Aug;37(34):4735-4749. doi: 10.1038/s41388-018-0318-9. Epub 2018 May 16.

32.

Intestinal failure: the evolving demographic and patient outcomes on home parenteral nutrition.

Brown SK, Davies N, Smyth E, Heather N, Cole C, Keys SC, Beattie RM, Batra A.

Acta Paediatr. 2018 Dec;107(12):2207-2211. doi: 10.1111/apa.14401. Epub 2018 Jun 8.

PMID:
29754463
33.

Reducing challenging behaviour of adults with intellectual disabilities in supported accommodation: A cluster randomized controlled trial of setting-wide positive behaviour support.

McGill P, Vanono L, Clover W, Smyth E, Cooper V, Hopkins L, Barratt N, Joyce C, Henderson K, Sekasi S, Davis S, Deveau R.

Res Dev Disabil. 2018 Oct;81:143-154. doi: 10.1016/j.ridd.2018.04.020. Epub 2018 May 8.

34.

Immune Checkpoint Inhibition in Gastro-Oesophageal Cancer.

Smyth E, Thuss-Patience PC.

Oncol Res Treat. 2018;41(5):272-280. doi: 10.1159/000489099. Epub 2018 Apr 27.

35.

Plant controls on Late Quaternary whole ecosystem structure and function.

Jeffers ES, Whitehouse NJ, Lister A, Plunkett G, Barratt P, Smyth E, Lamb P, Dee MW, Brooks SJ, Willis KJ, Froyd CA, Watson JE, Bonsall MB.

Ecol Lett. 2018 Jun;21(6):814-825. doi: 10.1111/ele.12944. Epub 2018 Mar 30.

PMID:
29601664
36.

Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.

Polom K, Böger C, Smyth E, Marrelli D, Behrens HM, Marano L, Becker T, Lordick F, Röcken C, Roviello F.

Eur J Surg Oncol. 2018 May;44(5):626-631. doi: 10.1016/j.ejso.2018.02.208. Epub 2018 Mar 2.

PMID:
29545085
37.

An interdisciplinary approach to improve surgical antimicrobial prophylaxis.

Conaty O, Gaughan L, Downey C, Carolan N, Brophy MJ, Kavanagh R, McNamara DAA, Smyth E, Burns K, Fitzpatrick F.

Int J Health Care Qual Assur. 2018 Mar 12;31(2):162-172. doi: 10.1108/IJHCQA-05-2017-0078.

PMID:
29504869
38.

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R, Rata M, Koh DM, Tunariu N, Collins D, Hulkki-Wilson S, Ragulan C, Spiteri I, Moorcraft SY, Chau I, Rao S, Watkins D, Fotiadis N, Bali M, Darvish-Damavandi M, Lote H, Eltahir Z, Smyth EC, Begum R, Clarke PA, Hahne JC, Dowsett M, de Bono J, Workman P, Sadanandam A, Fassan M, Sansom OJ, Eccles S, Starling N, Braconi C, Sottoriva A, Robinson SP, Cunningham D, Valeri N.

Science. 2018 Feb 23;359(6378):920-926. doi: 10.1126/science.aao2774.

39.

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial.

Davarzani N, Hutchins GGA, West NP, Hewitt LC, Nankivell M, Cunningham D, Allum WH, Smyth E, Valeri N, Langley RE, Grabsch HI.

Histopathology. 2018 Jun;72(7):1180-1188. doi: 10.1111/his.13491. Epub 2018 Mar 25.

40.

Hand hygiene "hall monitors": Leveraging the Hawthorne effect.

McDonald EG, Smyth E, Smyth L, Lee TC.

Am J Infect Control. 2018 Jun;46(6):706-707. doi: 10.1016/j.ajic.2017.11.030. Epub 2018 Feb 1.

PMID:
29361363
41.

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.

Tomasello G, Valeri N, Ghidini M, Smyth EC, Liguigli W, Toppo L, Mattioli R, Curti A, Hahne JC, Negri FM, Panni S, Ratti M, Lazzarelli S, Gerevini F, Colombi C, Panni A, Rovatti M, Treccani L, Martinotti M, Passalacqua R.

Oncotarget. 2017 Dec 4;8(67):111795-111806. doi: 10.18632/oncotarget.22909. eCollection 2017 Dec 19.

42.

The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.

Polom K, Marrelli D, Smyth EC, Voglino C, Roviello G, Pascale V, Varas J, Vindigni C, Roviello F.

Surg Innov. 2018 Apr;25(2):99-104. doi: 10.1177/1553350617751461. Epub 2018 Jan 5.

PMID:
29303062
43.

Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus.

Narayan N, Owen DR, Mandhair H, Smyth E, Carlucci F, Saleem A, Gunn RN, Rabiner EA, Wells L, Dakin SG, Sabokbar A, Taylor PC.

J Nucl Med. 2018 Jul;59(7):1125-1132. doi: 10.2967/jnumed.117.202200. Epub 2018 Jan 4.

44.

Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma.

Michalarea V, Smyth EC.

J Thorac Dis. 2017 Sep;9(9):2868-2870. doi: 10.21037/jtd.2017.08.148. No abstract available.

45.

Refinement of Mouse Protocols for the Study of Platelet Thromboembolic Responses In Vivo.

Rauzi F, Smyth E, Emerson M.

Thromb Haemost. 2017 Dec;117(12):2283-2290. doi: 10.1160/TH17-04-0250. Epub 2017 Dec 6.

46.

Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.

Stack JR, Madigan A, Helbert L, Dunne E, Gardiner EE, Andrews RK, Finan R, Smyth E, Kenny D, McCarthy GM.

PLoS One. 2017 Nov 15;12(11):e0188027. doi: 10.1371/journal.pone.0188027. eCollection 2017.

47.

MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.

Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R, Clarke P, Bosma E, Simbolo M, Scarpa A, Yu S, Cole R, Smyth E, Mateos JF, Begum R, Hezelova B, Eltahir Z, Wotherspoon A, Fotiadis N, Bali MA, Nepal C, Khan K, Stubbs M, Hahne JC, Gasparini P, Guzzardo V, Croce CM, Eccles S, Fassan M, Cunningham D, Andersen JB, Workman P, Valeri N, Braconi C.

Gastroenterology. 2018 Mar;154(4):1066-1079.e5. doi: 10.1053/j.gastro.2017.10.043. Epub 2017 Nov 4.

48.

Missing a GOLDen opportunity in gastric cancer.

Smyth E.

Lancet Oncol. 2017 Dec;18(12):1561-1563. doi: 10.1016/S1470-2045(17)30719-2. Epub 2017 Nov 2. No abstract available.

PMID:
29103869
49.

Response to 'Effects of diesel exhaust particles on coagulation'.

Smyth E, Solomon A, Birrell MA, Smallwood MJ, Winyard PG, Tetley TD, Emerson M.

Br J Pharmacol. 2017 Nov;174(22):4200. doi: 10.1111/bph.14032. Epub 2017 Oct 10. No abstract available.

50.

Adjuvant Chemotherapy Following Neoadjuvant Chemotherapy Plus Surgery for Patients With Gastroesophageal Cancer-Is There Room for Improvement?

Smyth EC, Cunningham D.

JAMA Oncol. 2018 Jan 1;4(1):38-39. doi: 10.1001/jamaoncol.2017.2792. No abstract available.

Supplemental Content

Support Center